Together, we can help end the HIV epidemic for everyone, everywhere

Hear the stories of real HIV heroes working to make it happen.
Turning the impossible into reality

Turning the impossible into reality

We helped reinvent HIV treatment and prevention. And now, we’re working together to help revolutionize what’s possible.

Meet our collaborators who make our work possible

SHIP & Gilead HIV


Dr. Kate Leyritana is dismantling stigma through compassionate care in the Philippines.


Dr. Jean Robert at Le Dispensaire, from the Montreal region, goes beyond the medicine with his patients.
Dr. Peter Centre & Gilead HIV

Dr. Peter Centre Gilead HIV

The Dr. Peter Centre is pioneering a holistic approach to HIV treatment and care in Vancouver.


Wake Forest University is creating a culture of empathy within faith communities in the Southern U.S.

A Doctor Sowing Seeds of Hope.

When a world-renowned hospital for HIV treatment and prevention was faced with barriers to patient care, one doctor used his voice to improve the quality of care for its future.

Dr. Moussa Seydi worked at Fann Hospital in Senegal for 15 years before rising to become the Head of Infectious and Tropical Diseases. Unfortunately, over this time, the hospital fell into disrepair due to natural disasters. As a leader, his mission was to restore Fann Hospital with new facilities to match their exemplary standards of care.

Gilead and Dr. Seydi had previously combined efforts as a part of the African Society of Infectious Disease, so when Dr. Seydi reached out about his mission, Gilead swiftly supported the cause with a grant to kickstart his project. 

With access to more resources and additional support through capturing the attention of the Senegalese government, Dr. Seydi was able to design a new, state-of-the-art facility.

Check Out the Full Story

Follow @GileadSciences for updates on this story and more.

Dr. Moussa Seydi
Dr. Moussa Seydi
Our vision

Ending the epidemic for everyone, everywhere

Decades of scientific innovation, partnership, and advocacy helped transform HIV from a fatal diagnosis to one that could be managed and prevented. Now, we’ll continue to support the wellness of all people impacted by HIV until the virus is eliminated.


Developing innovations

We developed the first HIV single tablet regimen and the first oral therapy to prevent HIV, but we’re still researching new strategies.


Advancing equitable care

We’ve forged partnerships to expand access to our life-saving medicines and continue to help facilitate treatment options.


Transformative collaboration

Pervasive prejudice perpetuates stigma surrounding HIV. We’re working closely with communities to fight discrimination.

Gilead’s commitment to ending the epidemic

Where we’ve been

Gilead created the first single-tablet HIV treatment and the first medicines to reduce the risk of infection.1 Gilead is proud to be recognized as the largest private funder of non-profit HIV programs in the U.S., and third largest in the world to date.2



Where we are

We’ve been teaming up with organizations to improve care globally. We’ve launched initiatives like COMPASS, RADIAN®, and Zeroing In™, while growing existing programs like AIDSVu. We are even raising awareness of HIV in Japan with a comic book.

Where we’re headed

We are adapting our approach to HIV treatment and prevention to better support people and communities impacted by the disease. We’re also continuing to fight to end the HIV epidemic, with the goal of achieving a functional cure for HIV.

Learn more about Gilead’s HIV advocacy
AIDS 2022 29 July - 2 August
AIDS 2022 is bringing the globe together to discuss future research agendas and to mobilize communities to improve public health. We’re proud to be leading a symposium as part of this year’s programming.

Working Together to End the Epidemic: Guided by the Voices on the Ground.

Join us for a presentation

Monday, August 1st  •  8am–9am

We’ll be showcasing how innovation, resilience, and community-led initiatives will help us meet challenges in ending the global HIV epidemic.

See our press release for more details.

Shonda Jones

Our presenter

Shonda Jones

Principal Investigator for the Gilead COMPASS Faith Coordinating Centre at Wake Forest University

Featuring each of our collaborator stories, followed by a panel discussion with Michael Angelo Marquez, MD; Jean Robert, MD; and Abby Charles, MPH; moderated by Alex Kalomparis, Gilead Senior Vice President, Public Affairs.

Mark your calendars now

RADIAN Symposium
Friday • 1:00-2:30pm
Africa HIV Cure Research Symposium
Friday • 2:45-4:15pm
Gilead Community Hub @ the Gilead Booth - Us Helping Us
Friday • 3:15-3:45pm
Gilead Community Hub @ the Gilead Booth - Fundo Positivo
Saturday • 3:15-3:45pm